|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FATE | Chu Yu-Waye | Chief Medical Officer | Apr 18 | Sale | 6.57 | 2,532 | 16,648 | 140,676 | Apr 19 04:07 PM |
| FATE | Chu Yu-Waye | Chief Medical Officer | Jan 10 | Sale | 5.24 | 7,825 | 41,003 | 143,208 | Jan 11 04:05 PM |
| FATE | Chu Yu-Waye | Chief Medical Officer | Apr 19 | Sale | 35.37 | 4,062 | 143,673 | 151,033 | Apr 21 04:04 PM |
| FATE | Chu Yu-Waye | Senior VP Clinical Development | Jan 11 | Sale | 48.51 | 3,965 | 192,340 | 121,793 | Jan 13 04:05 PM |
| FATE | Chu Yu-Waye | Senior VP Clinical Development | Dec 10 | Option Exercise | 16.32 | 7,500 | 122,400 | 133,258 | Dec 13 05:53 PM |
| FATE | Chu Yu-Waye | Senior VP Clinical Development | Dec 10 | Sale | 51.46 | 7,500 | 385,948 | 125,758 | Dec 13 05:53 PM |
| FATE | Chu Yu-Waye | Senior VP Clinical Development | Apr 16 | Sale | 83.30 | 3,275 | 272,809 | 64,800 | Apr 20 04:00 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite